Intradermal HBV vaccination is preferable in non-responders

Nature Reviews Nephrology

Volumn 5, Issue 11, 2009, Pages 616-617

  Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE;

ANTIBODY TITER; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS A H1N1; PATIENT CARE; PRIORITY JOURNAL; RISK REDUCTION; SHORT SURVEY; THERAPY EFFECT; TREATMENT RESPONSE; VACCINATION; VIRUS IMMUNITY; CHRONIC KIDNEY FAILURE; HEPATITIS B; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; NOTE; RENAL REPLACEMENT THERAPY; RISK FACTOR;

HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; INJECTIONS, INTRADERMAL; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK FACTORS;

EID: 70350502797     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.166     Document Type: Short Survey

References (8)

1. Vanholder, R., Van Loo, A., Dohndt, A. M., De smet, R. & Ringoir, S. influence of uremia and hemodialysis on host defense and infection. Nephrol. Dial. Transplant. 11, 593-598 (1996).
2. Caillat-Zucman, S. et al. Distinct HLA class ii alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 53, 1626-1630 (1998).
3. Kayata, M. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients. Artif. Organs 26, 492-496 (2002).
4. Barraclough, K. A. et al. intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open- label randomized controlled trial in nonresponders to primary vaccination. Am. J. Kidney Dis. 54, 95-103 (2009).
5. Propst, T., Propst, A., Lhotta, K., Vogel, W. & König, P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am. J. Kidney Dis. 32, 1041-1045 (1998).
6. Mat, O., Mestrez, F., Beauwens, R., Muniz-Martinez, M. C. & Dhaene, M. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years. Hemodial. Int. 10, 49-55 (2006).
7. Fabrizi, F., Dixit, V., Magnini, M., Elli, A. & Martin, P. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment. Pharmacol. Ther. 24, 497-506 (2006).
8. Belshe, R. B. et al. serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286-2294 (2004).